Akshara Singareeka-Raghavendra

20PUBLICATIONS
82CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Midwifery not elsewhere classifiedHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Mar 19, 2026
Tucatinib-trastuzumab-capecitabine for treatment of leptomeningeal metastasis in women with HER2+ breast cancer: TBCRC049 phase 2 study results.

Rashmi K Murthy, Barbara J O'Brien, Donald A Berry

|Mar 12, 2026
Ionizing Radiation Enhances Prognostically Significant Cellular Immunity Programs in the Brain Metastasis Microenvironment.

Kazutaka Fukumura, Peixin Jiang, Debra Nana Yeboa

|Feb 12, 2026
Weight Loss Patterns and Clinical Outcomes of GLP1 Receptor Agonists in Breast Cancer Survivors.

Jasmine S Sukumar, Akshara S Raghavendra, Sarah Pasyar

|Jan 28, 2026
Prevalence and Outcomes of HER2-Low Versus HER2-0 Status in Patients with Metastatic Breast Cancer.

Akshara Singareeka Raghavendra, Diane D Liu, Senthil Damodaran

|Jan 12, 2026
Personalizing therapies over the course of hormone receptor-positive/HER2-negative metastatic breast cancer.

Akshara Singareeka Raghavendra, Senthil Damodaran, Carlos H Barcenas

|Jan 26, 2025
Phase I trial of hydroxychloroquine to enhance palbociclib and letrozole efficacy in ER+/HER2- breast cancer.

Akshara Singareeka Raghavendra, Nicole M Kettner, Danielle Kwiatkowski

Pageof 4

Frequent Collaborators

15 joint publications

Debu Tripathy

6 joint publications

Carlos H Barcenas

3 joint publications

Rashmi K Murthy

3 joint publications

Kelly K Hunt